Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Case for Pre-Emptive Pharmacogenetic Screening in South Africa. | J Pers Med | 2024 | 38276236 | PubTator, text mining | PubMed |
| Personalized Chronomodulated 5-Fluorouracil Treatment: A Physiologically-Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy. | Clin Pharmacol Ther | 2024 | 38264789 | PubTator, text mining | PubMed |
| Risk of Sperm Disorders and Impaired Fertility in Frozen-Thawed Bull Semen: A Genome-Wide Association Study. | Animals (Basel) | 2024 | 38254422 | PubTator, text mining | PubMed |
| Bioinformatic analysis reveals an association between Metadherin with breast cancer prognosis and tumor immune infiltration. | Sci Rep | 2024 | 38253625 | PubTator, text mining | PubMed |
| Single variant, yet "double trouble": TSC and KBG syndrome because of a large de novo inversion. | Life Sci Alliance | 2024 | 38253421 | PubTator, text mining | PubMed |
| Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. | Curr Oncol | 2024 | 38248103 | PubTator, text mining | PubMed |
| Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype. | Discov Oncol | 2024 | 38228856 | PubTator, text mining | PubMed |
| Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis. | Br J Cancer | 2024 | 38225422 | PubTator, text mining | PubMed |
| Predictive factors for the development of capecitabine-induced hand-foot syndrome: a retrospective observational cohort study. | Ann Med Surg (Lond) | 2024 | 38222767 | PubTator, text mining | PubMed |
| Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity. | Pharmacogenomics J | 2024 | 38216550 | PubTator, text mining | PubMed |
| Common dihydropyrimidinase ( DPYS ) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort. | Pharmacogenet Genomics | 2024 | 38215018 | PubTator, text mining | PubMed |
| Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer. | JAMA Netw Open | 2024 | 38206623 | PubTator, text mining | PubMed |
| Bacterial tolerance and detoxification of cyanide, arsenic and heavy metals: Holistic approaches applied to bioremediation of industrial complex wastes. | Microb Biotechnol | 2024 | 38206076 | PubTator, text mining | PubMed |
| Anus preservation in low rectal adenocarcinoma based on MMR/MSI status (APRAM): a study protocol for a randomised, controlled, open-label, multicentre phase III trial. | BMC Cancer | 2024 | 38200410 | PubTator, text mining | PubMed |
| Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. | Nat Med | 2024 | 38200255 | PubTator, text mining | PubMed |
| A Rare Cause and Management of Ventricular Fibrillation: 5-Fluorouracil Toxicity. | Arq Bras Cardiol | 2024 | 38198360 | PubTator, text mining | PubMed |
| Building a vertically integrated genomic learning health system: The biobank at the Colorado Center for Personalized Medicine. | Am J Hum Genet | 2024 | 38181729 | PubTator, text mining | PubMed |
| Development of a low back pain care pathway in an academic hospital system: results of a consensus process. | J Orthop Surg Res | 2024 | 38169412 | PubTator, text mining | PubMed |
| 'A novel TRIP4 Variant Associated with Peripheral Neuropathy: Expanding the Clinical and Genetic Spectrum of ASC1-Related Myopathy'. | J Neuromuscul Dis | 2024 | 38143368 | PubTator, text mining | PubMed |
| Updated DPYD HapB3 haplotype structure and implications for pharmacogenomic testing. | Clin Transl Sci | 2024 | 38129972 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=16